- Home
- AGRO vs JANX Comparison
AGRO vs JANX Comparison
Compare AGRO & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGRO | JANX |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.7M | 890.8M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AGRO | JANX |
|---|---|---|
| Price | $8.61 | $13.20 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $8.17 | ★ $57.36 |
| AVG Volume (30 Days) | 476.2K | ★ 1.7M |
| Earning Date | 03-16-2026 | 03-09-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $1,386,018,000.00 | $10,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.64 | N/A |
| P/E Ratio | $37.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.89 | $12.12 |
| 52 Week High | $11.79 | $38.42 |
Technical Indicators
Market Signals| Indicator | AGRO | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 46.25 |
| Support Level | $8.56 | $12.74 |
| Resistance Level | $9.01 | $13.61 |
| Average True Range (ATR) | 0.30 | 0.67 |
| MACD | -0.05 | 0.12 |
| Stochastic Oscillator | 27.43 | 52.05 |
Price Performance
Historical ComparisonAbout AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.